Social and Emotional Impairment in Children and Adolescents with ADHD and the Impact on Quality of LifeWEHMEIER, Peter M; SCHACHT, Alexander; BARKLEY, Russell A et al.Journal of adolescent health. 2010, Vol 46, Num 3, pp 209-217, issn 1054-139X, 9 p.Article

Depression symptom clusters and their predictive value for treatment outcomes: Results from an individual patient data meta-analysis of duloxetine trialsSCHACHT, Alexander; GORWOOD, Philip; BOYCE, Philip et al.Journal of psychiatric research. 2014, Vol 53, pp 54-61, issn 0022-3956, 8 p.Article

Treatment response for acute depression is not associated with number of previous episodes: Lack of evidence for a clinical staging model for major depressive disorderDODD, Seetal; BERK, Michael; KELIN, Katarina et al.Journal of affective disorders. 2013, Vol 150, Num 2, pp 344-349, issn 0165-0327, 6 p.Article

Quality of Life and Attention-Deficit/Hyperactivity Disorder Core Symptoms: A Pooled Analysis of 5 Non-US Atomoxetine Clinical TrialsESCOBAR, Rodrigo; SCHACHT, Alexander; WEHMEIER, Peter M et al.Journal of clinical psychopharmacology. 2010, Vol 30, Num 2, pp 145-151, issn 0271-0749, 7 p.Article

Differential 3-Year Effects of First- Versus Second-Generation Antipsychotics on Subjective Well-Being in Schizophrenia Using Marginal Structural ModelsLAMBERT, Martin; SCHIMMELMANN, Benno G; DITTMANN, Ralf W et al.Journal of clinical psychopharmacology. 2011, Vol 31, Num 2, pp 226-230, issn 0271-0749, 5 p.Article

Validation of a Clinical Global Impression Scale for Aggression (CGI-A) in a sample of 558 psychiatric patientsHUBER, Christian G; LAMBERT, Martin; NABER, Dieter et al.Schizophrenia research. 2008, Vol 100, Num 1-3, pp 342-348, issn 0920-9964, 7 p.Article

Effects of clozapine and olanzapine on cytokine systems are closely linked to weight gain and drug-induced feverKLUGE, Michael; SCHULD, Andreas; SCHACHT, Alexander et al.Psychoneuroendocrinology. 2009, Vol 34, Num 1, pp 118-128, issn 0306-4530, 11 p.Article

Association of subjective well-being, symptoms, and side effects with compliance after 12 months of treatment in schizophreniaKAROW, Anne; CZEKALLA, Joerg; DITTMANN, Ralf W et al.The Journal of clinical psychiatry. 2007, Vol 68, Num 1, pp 75-80, issn 0160-6689, 6 p.Article

Prediction of remission as a combination of symptomatic and functional remission and adequate subjective well-being in 2960 patients with schizophreniaLAMBERT, Martin; SCHIMMELMANN, Benno G; NABER, Dieter et al.The Journal of clinical psychiatry. 2006, Vol 67, Num 11, pp 1690-1697, issn 0160-6689, 8 p.Article

Impact of patient selection and study characteristics on signal detection in placebo-controlled trials with antidepressantsMANCINI, Michele; WADE, Alan G; PERUGI, Giulio et al.Journal of psychiatric research. 2014, Vol 51, pp 21-29, issn 0022-3956, 9 p.Article

Early vs. conventional switching of antidepressants in patients with MDD and moderate to severe pain: A double-blind randomized studyROMERA, Irene; PEREZ, Victor; MENCHON, Jose Manuel et al.Journal of affective disorders. 2012, Vol 143, Num 1-3, pp 47-55, issn 0165-0327, 9 p.Article

Patterns of physician and patient rated quality of life during antipsychotic treatment in outpatients with schizophreniaWEHMEIER, Peter M; KLUGE, Michael; SCHACHT, Alexander et al.Journal of psychiatric research. 2008, Vol 42, Num 8, pp 676-683, issn 0022-3956, 8 p.Article

Olanzapine and clozapine differently affect sleep in patients with schizophrenia: Results from a double-blind, polysomnographic study and review of the literatureKLUGE, Michael; SCHACHT, Alexander; SCHULD, Andreas et al.Schizophrenia research. 2014, Vol 152, Num 1, pp 255-260, issn 0920-9964, 6 p.Article

Correlation of physician and patient rated quality of life during antipsychotic treatment in outpatients with schizophreniaWEHMEIER, Peter M; KLUGE, Michael; SCHACHT, Alexander et al.Schizophrenia research. 2007, Vol 91, Num 1-3, pp 178-186, issn 0920-9964, 9 p.Article

Quality of life and subjective well-being during treatment with antipsychotics in out-patients with schizophreniaWEHMEIER, Peter M; KLUGE, Michael; SCHNEIDER, Edith et al.Progress in neuro-psychopharmacology & biological psychiatry. 2007, Vol 31, Num 3, pp 703-712, issn 0278-5846, 10 p.Article

An ultra-low energy method for rapidly pre-concentrating microalgaeSHUMAN, Teodora Rutar; MASON, Gregory; MARSOLEK, Michael D et al.Bioresource technology. 2014, Vol 158, pp 217-224, issn 0960-8524, 8 p.Article

Neuropathic pain phenotyping as a predictor of treatment response in painful diabetic neuropathy: Data from the randomized, double-blind, COMBO-DN studyBOUHASSIRA, Didier; WILHELM, Stefan; MARCHETTINI, Paolo et al.Pain (Amsterdam). 2014, Vol 155, Num 10, pp 2171-2179, issn 0304-3959, 9 p.Article

Duloxetine and pregabalin: High-dose monotherapy or their combination? The COMBO-DN study - a multinational, randomized, double-blind, parallel-group study in patients with diabetic peripheral neuropathic painTESFAYE, Solomon; WILHELM, Stefan; LLEDO, Alberto et al.Pain (Amsterdam). 2013, Vol 154, Num 12, pp 2616-2625, issn 0304-3959, 10 p.Article

Early Switch Strategy in Patients With Major Depressive Disorder: A Double-Blind, Randomized StudyROMERA, Irene; PEREZ, Victor; MENCHON, Jose Manuel et al.Journal of clinical psychopharmacology. 2012, Vol 32, Num 4, pp 479-486, issn 0271-0749, 8 p.Article

Clozapine and olanzapine are associated with food craving and binge eating : Results from A randomized double-blind studyKLUGE, Michael; SCHULD, Andreas; HIMMERICH, Hubertus et al.Journal of clinical psychopharmacology. 2007, Vol 27, Num 6, pp 662-666, issn 0271-0749, 5 p.Article

Does Atomoxetine Improve Executive Function, Inhibitory Control, and Hyperactivity?: Results From a Placebo-Controlled Trial Using Quantitative Measurement TechnologyWEHMEIER, Peter M; SCHACHT, Alexander; ULBERSTAD, Fredrik et al.Journal of clinical psychopharmacology. 2012, Vol 32, Num 5, pp 653-660, issn 0271-0749, 8 p.Article

A Randomized Double-Blind Study of Atomoxetine Versus Placebo for Attention- Deficit/Hyperactivity Disorder Symptoms in Children With Autism Spectrum DisorderHARFTERKAMP, Myriam; DE LOO-NEUS, Gigi Van; MINDERAA, Ruud B et al.Journal of the American Academy of Child and Adolescent Psychiatry. 2012, Vol 51, Num 7, pp 733-741, issn 0890-8567, 9 p.Article

Long-term patterns of subjective wellbeing in schizophrenia : Cluster, predictors of cluster affiliation, and their relation to recovery criteria in 2842 patients followed over 3 yearsLAMBERT, Martin; SCHIMMELMANN, Benno G; SCHACHT, Alexander et al.Schizophrenia research. 2009, Vol 107, Num 2-3, pp 165-172, issn 0920-9964, 8 p.Article

Atomoxetine improves patient and family coping in attention deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled study in Swedish children and adolescentsSVANBORG, Pär; THERNLUND, Gunilla; GUSTAFSSON, Per A et al.European child & adolescent psychiatry. 2009, Vol 18, Num 12, pp 725-735, issn 1018-8827, 11 p.Article